Equity Profile

STE

STERIS plc

Health CareHealth Care Equipment$21.2B

Aug5Wed

Pre-Earnings Brief

UpcomingQ1-2027After Close5:00 PM EDT

Company Snapshot

STERIS plc is a global leader in health care equipment, providing essential products and services to hospitals and healthcare facilities. With a market cap of $21 billion, the company plays a critical role in ensuring patient safety and infection control, which are increasingly important in today's healthcare landscape.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and will help gauge its financial health this quarter.

N/A

Revenue Growth

Revenue growth will indicate how well the company is expanding its market presence and meeting demand.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

STE Q1-2027 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+1.57%

Avg Stock Reaction

-0.34%

Last Quarter Recap

In the last quarter (Q4-2026), STERIS reported an EPS of $2.83, slightly missing estimates. The stock reacted negatively, dropping 2.70% the following day.

Management Promises & Guidance

Focus on enhancing product offerings to improve market share.
Commitment to cost management to maintain profitability.
Plans for strategic acquisitions to bolster growth.

Expectations

Wall Street Expectations

Overall, expectations for STERIS are mixed, with uncertainty surrounding revenue growth and profitability. Investors are keenly watching for any signs of improvement in these areas.

Bull Case

If STERIS can demonstrate strong revenue growth and beat EPS expectations, it could signal a recovery and renewed investor confidence.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for this quarter?

EPS is a crucial metric that will indicate the company's profitability and could significantly impact stock performance.

How is revenue growth expected to trend in the upcoming quarters?

Understanding revenue growth will provide insights into the company's market position and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating STERIS's ability to innovate and capture market share, especially in infection control solutions.

Supporting Evidence

The company has a history of beating EPS estimates 75% of the time.

Recent insider buying suggests confidence in the company's future performance.

Key Risk

If the company announces a significant new product or partnership, it could shift market sentiment dramatically.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether STERIS can sustain growth in a competitive healthcare environment.

Bull Confirmed If

An EPS of $2.90 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $2.70 would confirm the bear case, suggesting ongoing challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±11.87%

Historical Avg

±1.0%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings report.

Options are pricing ±11.9% while STE has averaged ±1.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

28.7%

Calls (500)P/C Ratio: 11.00Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If STERIS beats expectations, history suggests the stock could see a modest increase, confirming a positive outlook.

In-Line / Cautious

If results are in line but cautious commentary is provided, the stock may remain stable but with limited upside.

Miss

A miss on earnings could lead to a decline, with history suggesting an average drop of around 0.85%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

3 buys·0 sells

Members

House only

Est. Notional

$3,003.00–$45,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their expected impact on revenue.
2Any commentary on cost management strategies and their effectiveness.
3Insights into market demand trends for health care equipment.
4Details on strategic acquisitions and their integration plans.
5Management's outlook on the competitive landscape in the health care sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and will help gauge its financial health this quarter.

N/A

Revenue Growth

Revenue growth will indicate how well the company is expanding its market presence and meeting demand.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

STE Q1-2027 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+1.57%

Avg Stock Reaction

-0.34%

Last Quarter Recap

In the last quarter (Q4-2026), STERIS reported an EPS of $2.83, slightly missing estimates. The stock reacted negatively, dropping 2.70% the following day.

Management Promises & Guidance

Focus on enhancing product offerings to improve market share.
Commitment to cost management to maintain profitability.
Plans for strategic acquisitions to bolster growth.

Expectations

Wall Street Expectations

Overall, expectations for STERIS are mixed, with uncertainty surrounding revenue growth and profitability. Investors are keenly watching for any signs of improvement in these areas.

Bull Case

If STERIS can demonstrate strong revenue growth and beat EPS expectations, it could signal a recovery and renewed investor confidence.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for this quarter?

EPS is a crucial metric that will indicate the company's profitability and could significantly impact stock performance.

How is revenue growth expected to trend in the upcoming quarters?

Understanding revenue growth will provide insights into the company's market position and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating STERIS's ability to innovate and capture market share, especially in infection control solutions.

Supporting Evidence

The company has a history of beating EPS estimates 75% of the time.

Recent insider buying suggests confidence in the company's future performance.

Key Risk

If the company announces a significant new product or partnership, it could shift market sentiment dramatically.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether STERIS can sustain growth in a competitive healthcare environment.

Bull Confirmed If

An EPS of $2.90 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $2.70 would confirm the bear case, suggesting ongoing challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±11.87%

Historical Avg

±1.0%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings report.

Options are pricing ±11.9% while STE has averaged ±1.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

28.7%

Calls (500)P/C Ratio: 11.00Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If STERIS beats expectations, history suggests the stock could see a modest increase, confirming a positive outlook.

In-Line / Cautious

If results are in line but cautious commentary is provided, the stock may remain stable but with limited upside.

Miss

A miss on earnings could lead to a decline, with history suggesting an average drop of around 0.85%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

3 buys·0 sells

Members

House only

Est. Notional

$3,003.00–$45,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their expected impact on revenue.
2Any commentary on cost management strategies and their effectiveness.
3Insights into market demand trends for health care equipment.
4Details on strategic acquisitions and their integration plans.
5Management's outlook on the competitive landscape in the health care sector.